Acrolein BSA Conjugate

Acrolein BSA Conjugate is a critical tool for detecting acrolein-modified proteins, which serve as biomarkers of oxidative stress and lipid peroxidation in the nervous system. Acrolein, a highly reactive α, β-unsaturated aldehyde, is generated during lipid degradation and inflammation, particularly under conditions of mitochondrial dysfunction and excitotoxicity. In neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and spinal cord injury, elevated acrolein levels correlate with neuronal damage, glial activation, and impaired synaptic function. Acrolein-modified proteins disrupt cytoskeletal integrity and promote neuroinflammation, contributing to progressive neurodegeneration. The BSA-conjugated form enables sensitive detection of acrolein adducts in immunoassays and tissue staining, supporting mechanistic studies and therapeutic screening in oxidative stress-related neuropathologies.

Acrolein BSA Conjugate, Acrolein (BSA) Conjugate, Acrolein (BSA) conjugate antigen, Acrolein-BSA Conjugate, Acrolein Conjugated to BSA, Acrolein BSA-Conjugated, BSA-conjugated acrolein, Acrolein Bovine Serum Albumin Conjugate, Acrolein (Bovine Serum Albumin) Conjugate, Acrolein (Bovine Serum Albumin) conjugate antigen, Acrolein-Bovine Serum Albumin Conjugate, Acrolein Conjugated to Bovine Serum Albumin, Acrolein Bovine Serum Albumin-Conjugated, Bovine Serum Albumin-conjugated acrolein, Bovine Serum Albumin conjugated with Acrolein, Acrolein-modified BSA